---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-013133"
form_type: "8-K"
ticker: "ANEB"
cik: "0001815974"
company_name: "Anebulo Pharmaceuticals, Inc."
filed_at: "2025-09-12T23:59:59+00:00"
generated_at: "2026-05-17T06:45:41.580107+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Anebulo updates on going private: Board to consider sale, merger, or other alternatives

## Summary
- Received inbound interest from potential financial and strategic partners after announcing going private on July 23, 2025.
- Board will review all strategic alternatives including going private, reverse stock split, asset sale, or merger.
- Company plans to hold special stockholder meeting to approve proposed reverse stock split while review continues.
- No assurance that process will result in a transaction; no deadline or definitive timetable set.
- Even if stockholders approve reverse stock split, Board could abandon it for any reason.

## SEC filing metadata
- accession: 0001493152-25-013133
- form_type: 8-K
- ticker: ANEB
- cik: 0001815974
- company_name: Anebulo Pharmaceuticals, Inc.
- filed_at: 2025-09-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815974/000149315225013133/0001493152-25-013133-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815974/000149315225013133/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-013133
- JSON: https://secwatch.observer/filing/0001493152-25-013133.json
- Plain text: https://secwatch.observer/filing/0001493152-25-013133.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.